For too long, the conversation around weight loss has been one-size-fits-all. Yet, men’s bodies, metabolisms, and health challenges are unique. At HeMed, we understand this. We’ve developed a comprehensive weight loss programme designed specifically for men, combining cutting-edge medical science with personalised, real-world support. Now, we are proud to integrate Mounjaro (tirzepatide), a revolutionary prescription medication, into our specialised programme.

Mounjaro is not just another weight loss drug. It’s a dual-action treatment that works with your body’s natural systems to regulate appetite and blood sugar, leading to significant and sustainable weight loss. When combined with the expert guidance, tailored nutrition, and fitness coaching of the HeMed programme, it represents a powerful new chapter in men’s health. This page will explain exactly how Mounjaro works, how the Hemed programme supports your journey, and how this combined approach, fully aligned with MHRA regulations, can help you finally take control of your weight and transform your health.

Ready to see if you’re eligible? Discover how Mounjaro and HeMed can help you achieve your weight loss goals. Take our quick assessment today.

Understanding Mounjaro and How It Works

Mounjaro, the brand name for the medication tirzepatide, represents a significant advancement in weight management. It is the first in a new class of medicines known as dual GIP and GLP-1 receptor agonists. But what does that mean for you? In simple terms, Mounjaro works by mimicking the effects of two naturally occurring hormones in your body that are crucial for managing hunger and blood sugar.

The Science of Satiety: GIP and GLP-1

Your gut produces hormones that signal to your brain when you’re full and help control how your body processes food and sugar. The two key hormones Mounjaro targets are:

• GLP-1 (Glucagon-like peptide-1): This hormone is released after you eat. It helps to lower blood sugar levels by stimulating insulin release, slows down the speed at which your stomach empties (making you feel fuller for longer), and acts on the appetite centres in your brain to reduce hunger and cravings.
• GIP (Glucose-dependent insulinotropic polypeptide): This hormone also plays a role in managing blood sugar and has been shown to decrease food intake and improve how the body breaks down sugar and fat.

Mounjaro is unique because it activates the receptors for both of these hormones. This dual-action mechanism is believed to be more effective for weight loss and blood sugar control than medications that only target the GLP-1 receptor. By enhancing these natural bodily signals, Mounjaro helps you feel satisfied with smaller portions, reduces persistent food cravings, and improves your body’s metabolic health.

Clinically Proven Efficacy

The effectiveness of Mounjaro is not just theoretical; it’s backed by extensive clinical research. The landmark SURMOUNT-1 clinical trial, published in the prestigious New England Journal of Medicine, demonstrated remarkable results. In this study, participants taking tirzepatide for weight management (without type 2 diabetes) achieved substantial and sustained weight loss over 72 weeks.

Key findings showed that participants on the highest dose of Mounjaro lost an average of nearly 21% of their body weight. This level of efficacy is a game-changer, approaching the results seen with some forms of bariatric surgery.

In the UK, the National Institute for Health and Care Excellence (NICE) has recognised this potential. In their Technology Appraisal Guidance [TA924], NICE recommends tirzepatide as an option for managing overweight and obesity in adults, in conjunction with a reduced-calorie diet and increased physical activity. This endorsement underscores its clinical value and cost-effectiveness within the UK healthcare framework.

How is Mounjaro Administered?

Mounjaro is a prescription-only medication administered as a once-weekly injection. It comes in a user-friendly, pre-filled pen, making the process simple and convenient. The injection is subcutaneous, meaning it goes just under the skin of your abdomen, thigh, or upper arm. Your HeMed clinical team will provide comprehensive training and support to ensure you are comfortable and confident with the administration process. The dosage typically starts low and is gradually increased by your doctor to minimise potential side effects and find the most effective dose for you.

It is crucial to remember that Mounjaro is not a cosmetic solution; it is a powerful medical treatment that requires a full consultation and prescription from a qualified healthcare professional.

The HeMed Programme: A Tailored Approach to Men’s Weight Loss

Medication alone is only part of the solution. Sustainable weight loss requires a holistic approach that addresses nutrition, physical activity, and the psychological aspects of health. This is where the HeMed programme provides the essential framework for your success. We don’t just give you a prescription; we give you a plan, a team, and the unwavering support you need to build lasting healthy habits.

Our programme is built on four core pillars, all designed with men’s health as the central focus:

Personalised Clinical Supervision: Your journey begins with a comprehensive online consultation. Our clinicians will assess your health history and determine if Mounjaro is a safe and appropriate option for you. Throughout the programme, you’ll have regular check-ins to monitor your progress, manage any side effects, and adjust your treatment plan as needed.

Continuous Progress Tracking and Support: We use technology to help you stay on track, but our support is deeply human. Through our app and regular consultations, we monitor your progress, celebrate your milestones, and provide the motivation and accountability needed to navigate challenges. You are not alone on this journey; the entire HeMed team is behind you.

Benefits of Combining Mounjaro and HeMed for Men

The true power of our approach lies in the synergy between Mounjaro and the HeMed programme. They work together to create a comprehensive ecosystem for success, where the medication makes lifestyle changes easier, and the lifestyle changes make the medication more effective.

Mounjaro works on a physiological level to reset your body’s relationship with food. By reducing your appetite and cravings, it breaks the cycle of overeating and gives you the headspace to make conscious, healthier choices. It creates the biological opportunity for change.

The HeMed programme provides the structure, knowledge, and support to seize that opportunity. We teach you what to eat, how to move, and why it matters, empowering you to build habits that will last long after you’ve reached your goal weight.

More Than Just Weight Loss

The benefits of this combined approach extend far beyond the number on the scales. For men, carrying excess weight, particularly around the abdomen, is linked to a host of serious health issues. By achieving significant weight loss, you can:

• Improve Cardiovascular Health: Reduce blood pressure, lower cholesterol levels, and decrease your risk of heart attack and stroke.
• Reduce the Risk of Type 2 Diabetes: Mounjaro is highly effective at improving blood sugar control, and weight loss is one of the most critical factors in preventing or even reversing type 2 diabetes.
• Boost Energy and Vitality: Shedding excess weight can lead to a dramatic increase in energy levels, reduced joint pain, and improved mobility.
• Enhance Mental Well-being: The journey of taking back control of your health is incredibly empowering. Many of our clients report significant improvements in self-esteem, confidence, body image, and overall mood.
• Support Hormonal Health: Excess body fat can negatively impact testosterone levels. Weight loss can help restore a healthier hormonal balance.

The HeMed programme is designed for busy lives. With remote consultations and a flexible app-based platform, you can integrate this transformative journey into your existing schedule without disruption.

Is Mounjaro Right for You? Considerations and Safety Information

Patient safety is our absolute priority. Mounjaro is a highly effective medication, but it is not suitable for everyone. A thorough medical evaluation with a HeMed clinician is essential to determine your eligibility.

Potential Side Effects

Like all medications, Mounjaro can cause side effects. The most common are gastrointestinal and are usually mild to moderate, often decreasing over time as your body adjusts. These can include:

• Nausea
• Diarrhoea
• Decreased appetite
• Vomiting
• Constipation
• Indigestion or abdominal pain

Our clinical team will guide you on how to manage these potential side effects, and the gradual dose-increase schedule is designed to minimise them.

Important Safety Information

Mounjaro is not suitable for individuals with certain medical conditions. You should not take Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also contraindicated for patients with a history of pancreatitis.

Before starting treatment, you must provide your doctor with a complete medical history, including all existing conditions and any other medications you are taking (including over-the-counter supplements).

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines in the UK work and are acceptably safe. You can find the official Patient Information Leaflet and further safety details on the MHRA Products website. Our clinical team adheres strictly to all MHRA and NICE guidelines to ensure your treatment is both safe and effective.

Disclaimer: The information provided on this landing page is for informational purposes only and does not constitute medical advice. It is not a substitute for a professional consultation with a qualified healthcare provider. Please consult with a doctor to determine if Mounjaro is an appropriate treatment for you.

Frequently Asked Questions (FAQ)

We understand you may have questions. Here are answers to some of the most common queries we receive about Mounjaro and the HeMed programme.

How much weight can I expect to lose with Mounjaro and HeMed?

Results vary from person to person, but clinical trials have shown very promising outcomes. In the SURMOUNT-1 trial, participants on the highest dose of Mounjaro lost an average of 20.9% of their starting body weight over 72 weeks. When combined with the structured support of the HeMed programme, you are placed in the best possible position to achieve significant and, crucially, sustainable results.

What are the potential side effects of Mounjaro?

The most common side effects are related to the digestive system, including nausea, diarrhoea, vomiting, and constipation. These are typically most noticeable when starting the medication or increasing the dose and tend to subside as your body adapts. The HeMed clinical team will provide strategies to help you manage these and will monitor you closely.

How long does it take to see results with Mounjaro?

You may start to notice a reduction in your appetite within the first few weeks of treatment. Noticeable weight loss typically follows over the first one to two months and continues throughout the course of treatment. Consistency with both the medication and the lifestyle changes recommended by the HeMed programme is key to seeing the best results.

How much does the HeMed programme cost?

The HeMed programme is a comprehensive subscription service that includes your clinical consultations, prescription for Mounjaro (if eligible), the medication itself delivered to your door, and ongoing support from our team of nutritionists and coaches. For detailed and up-to-date pricing information, please visit our pricing page or complete our initial assessment.

Can I combine Mounjaro with other weight loss medications?

No, you should not use Mounjaro in combination with other GLP-1 receptor agonist medications or any other prescription weight loss drugs, over-the-counter diet pills, or herbal supplements. It is vital to disclose all medications you are taking to your Hemed clinician during your consultation to ensure your safety.

Get Started Today: Take Control of Your Health with HeMed

You have the power to write a new story for your health. The combination of Mounjaro’s powerful medical benefits and the HeMed programme’s expert, tailored support provides a clear, effective, and sustainable path to achieving your weight loss goals. Stop the cycle of yo-yo dieting and start building a healthier, more confident future.

The first step is the simplest. Take our quick, confidential online assessment to see if you are eligible for the HeMed programme. There’s no obligation, but it could be the start of a life-changing journey.

Take our quick assessment now and begin your transformation.

References

1. National Centre for Biotechnology Information. (n.d.). StatPearls [Internet]. Retrieved July 28, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK551568/
2. Gasbjerg, L. S., Gabe, M. B. N., Hartmann, B., Christensen, M. B., Knop, F. K., & Rosenkilde, M. M. (2018). Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents. Peptides, 100, 173-181. https://doi.org/10.1016/j.peptides.2017.11.021
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Kushner, R. F. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
4. National Institute for Health and Care Excellence. (2024). Tirzepatide for treating type 2 diabetes in adults (NICE Technology appraisal guidance [TA924]). https://www.nice.org.uk/guidance/ta924
5. American Heart Association. (n.d.). Lifestyle changes for heart attack prevention. Retrieved July 28, 2025, from https://www.heart.org/en/health-topics/heart-attack/prevention/lifestyle-changes-for-heart-attack-prevention
6. Christensen, P., Ritz, C., Ingstrup, M., Louw, A., Vilsbøll, T., & Richelsen, B. (2013). Effect of weight loss on urinary incontinence and quality of life in obese women with urinary incontinence: A randomised clinical trial. JAMA Internal Medicine, 173(11), 1062–1068. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1656548
7. Fabricatore, A. N., Wadden, T. A., & Sarwer, D. B. (2004). Obesity and mental health. Clinics in Dermatology, 22(4), 332–337. https://www.sciencedirect.com/science/article/pii/S0738081X04000987
8. Khoo, J., Piantadosi, C., Duncan, R., Worthley, S. G., Jenkins, A., Noakes, M., & Wittert, G. A. (2013). Effects of a low-energy diet on sexual and endothelial function and lower urinary tract symptoms in obese men. The Journal of Sexual Medicine, 10(10), 2300–2310. https://pubmed.ncbi.nlm.nih.gov/23413895/